Search

The article focuses on the dry-eye disease or dysfunctional tear syndrome. It is stated that the disease is still an under-diagnosed and under-attended problem of the eye. Dry eye could be diagnosed based on patient's symptoms and patient's subjective descriptions of their symptoms vary. The severity and duration of the symptoms are very important in planning the treatment of dry eye. Initiation of anti-inflammatory agents such as topical cyclosporine is preferable to prevent worst condition.

The article focuses on the insights of ophthalmology professor Esen K. Akpek on the clinical significance of the invasion of ectoparasite Demodex in blepharitis. Topics covered include the skin problems associated with infestation of Demodex, the Demodex species detected in humans and the primary symptoms of demodicosis. Also mentioned is the need to look for the sign of cylindrical dandruff at the base of eyelashes.

The article explores the epidemiology of and risk factors for dry eye. It also examines ways in which glaucoma should enable ophthalmologists to better recognize these conditions to be treated appropriately. In this context, dry eye syndrome is defined as a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance and tear film inability, as well as potential damage to the ocular surface.

The article reports that artificial cornea is hope of ray for high-risk eyes. Presently, two artificial corneas have been approved by the U.S. Food and Drug Administration (FDA). Even then, none of the artificial corneas presently available are perfect and there is a need for developing better technology.